IP Library Granted Patent US 9,238,212
Granted Patent B2
US 9,238,212 · App. 14/316,149 · Granted Jan 19, 2016

Process and apparatus for treating a gas stream

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,238,212
App. No.
14/316,149
Granted
Jan 19, 2016
Kind
B2
Abstract

A process of treating hydrogen gas liberated from the acid or alkaline dissolution of a metal is provided. The process comprises a step of passing the liberated hydrogen gas through a reactor containing an oxidizing agent for oxidation of the hydrogen gas into water, followed by a step of regenerating the oxidizing agent. Also provided is an apparatus for carrying out the process, the apparatus comprising a reactor containing the oxidizing agent, wherein the reactor is at least partially immersed in an alumina bath.

Claims (60)

1. A heating apparatus comprising an alumina bath supplied with one or more external heating elements, wherein the alumina bath defines a cavity into which a reactor may be placed, the reactor comprising an oxidising agent for the oxidation of hydrogen gas into water.

2. The heating apparatus of claim 1 , wherein the oxidising agent comprises copper oxide.

3. The apparatus of claim 2 , wherein the oxidising agent is diluted with an inert diluent.

4. The heating apparatus of claim 3 , wherein the oxidising agent is diluted 50% by weight with the inert diluent.

5. The heating apparatus of claim 2 , wherein hydrogen gas is passed into the CuO reactor in which the hydrogen gas is oxidised into water while the CuO is converted into Cu.

6. The heating apparatus of claim 5 , wherein a stream of air-containing nitrogen gas (N2/air) is fed into the CuO reactor to oxidise Cu in order to regenerate CuO.

7. The heating apparatus of claim 2 , wherein the oxidising agent is selected from R3-11G and R3-17 catalysts.

8. The heating apparatus of claim 1 , wherein the reactor is at least partially immersed in the alumina bath.

9. The heating apparatus of claim 8 , wherein the reactor is completely immersed in the alumina bath.

10. The heating apparatus of claim 1 , wherein the one or more external heating elements is selected from a collar, a jacket, and a heating coil.

11. The heating apparatus of claim 1 , wherein the external heating elements are electrically heated.

12. The hearing apparatus of claim 1 , wherein the alumina bath is a heat exchanger.

13. The heating apparatus of claim 1 , wherein the alumina bath heats up the reactor to an initial reaction temperature with no deleterious effects to the oxidising agent material.

14. The heating apparatus of claim 13 , wherein the initial reaction temperature is 200° C.

15. The heating apparatus of claim 1 , wherein the alumina bath comprises outer walls taking the form of a substantially cylindrical or cuboidal container.

16. The heating apparatus of claim 15 , wherein the outer walls of the alumina bath comprise stainless steel or aluminum.

17. The heating apparatus of claim 1 , wherein the reactor comprises less than 12 kg of the oxidising agent.

18. An apparatus for treating hydrogen gas liberated from the acid or alkaline dissolution of a metal, the apparatus comprising a reactor comprising an oxidising agent for the oxidation of hydrogen gas into water, wherein the reactor is heated with one or more heating elements positioned in contact with the reactor, wherein the liberated hydrogen gas is passed through the reactor followed by regeneration of the oxidising agent, and wherein the oxidising agent comprises a metal oxide in bulk form or a metal oxide finely dispersed on the surface of an inert support.

19. The apparatus of claim 18 , wherein the one or more heating elements are selected from one or more heated clamps or bands.

20. The apparatus of claim 19 , wherein the bands may be in the form of a single helical band which runs along at least part of a length of the reactor.

21. The apparatus of claim 18 , wherein the heating elements are electrically heated.

22. The apparatus of claim 18 , wherein the one or more heating elements heat up the reactor to an initial reaction temperature with no deleterious effects to the oxidising agent material.

23. The apparatus of claim 22 , wherein the initial reaction temperature is 200° C.

24. The apparatus of claim 18 , wherein the oxidising agent comprises copper oxide.

25. The apparatus of claim 24 , wherein the oxidising agent is selected from R3-11G and R3-17 catalysts.

26. The apparatus of claim 18 , wherein the oxidising agent is diluted with an inert diluent.

27. The apparatus of claim 26 , wherein the inert diluent comprises stainless steel pellets.

28. The apparatus of claim 26 , wherein the oxidising agent is diluted 50% by weight with the inert diluent.

29. The apparatus of claim 18 , wherein the reactor further comprises a first conduit.

30. The apparatus of claim 29 , wherein the liberated hydrogen gas enters the reactor through the first conduit.

31. The apparatus of claim 29 , wherein a mixture of nitrogen and air is introduced to the reactor through the first conduit for the regeneration of the oxidising agent.

32. The apparatus of claim 18 , wherein the reactor further comprises a venting conduit.

33. The apparatus of claim 32 , wherein gaseous water exits the reactor through the venting conduit.

34. The apparatus of claim 32 , wherein waste nitrogen gas exist the reactor through the venting conduit after the regeneration of the oxidising agent.

35. The apparatus of claim 18 , wherein the reactor comprises less than 12 kg of the oxidising agent.

36. An apparatus for treating hydrogen gas liberated from the acid or alkaline dissolution of a metal, the apparatus comprising a reactor comprising an oxidising agent diluted with an inert diluent for the oxidation of hydrogen gas into water, wherein the reactor is at least partially immersed in an alumina bath supplied with one or more external heating elements, and wherein the liberated hydrogen gas is passed through the reactor followed by regeneration of the oxidizing agent.

37. The apparatus of claim 36 , wherein the one or more heating elements are selected from a collar, a jacket, and a heating coil.

38. The apparatus of claim 36 , wherein the heating elements are electrically heated.

39. The apparatus of claim 36 , wherein the alumina bath heats up the reactor to an initial reaction temperature with no deleterious effects to the oxidising agent material.

40. The apparatus of claim 30 , wherein the initial reaction temperature is 200° C.

41. The apparatus of claim 36 , wherein the oxidising agent comprises copper oxide.

42. The apparatus of claim 41 , wherein the oxidising agent is selected from R3-11G and R3-17 catalysts.

43. The apparatus of claim 36 , wherein the oxidising agent is diluted with an inert diluent.

44. The apparatus of claim 43 , wherein the inert diluent comprises stainless steel pellets.

45. The apparatus of claim 43 , wherein the oxidising agent is diluted 50% by weight with the inert diluent.

46. The apparatus of claim 36 , wherein the reactor further comprises a first conduit.

47. The apparatus of claim 46 , wherein the liberated hydrogen gas enters the reactor through the first conduit.

48. The apparatus of claim 46 , wherein a mixture of nitrogen and air is introduced to the reactor through the first conduit for the regeneration of the oxidising agent.

49. The apparatus of claim 36 , wherein the reactor further comprises a venting conduit.

50. The apparatus of claim 49 , wherein gaseous water exits the reactor through the venting conduit.

51. The apparatus of claim 49 , wherein waste nitrogen gas exist the reactor through the venting conduit after the regeneration of the oxidising agent.

52. The apparatus of claim 36 , wherein the reactor comprises less than 12 kg of the oxidising agent.

53. A process for treating hydrogen gas liberated from the acid or alkaline dissolution of a metal using the apparatus of claim 18 , the process comprising passing the liberated hydrogen gas through the reactor and regenerating the oxidising agent.

54. The process of claim 53 , wherein the oxidation of hydrogen gas into water is greater than 95%.

55. The process of claim 53 , wherein the regeneration of the oxidising agent is greater than 90%.

56. The process of claim 53 , wherein the reactor reaches steady state conditions in 3 hours.

57. A process for treating hydrogen gas liberated from the acid or alkaline dissolution of a metal using the apparatus of claim 36 , the process comprising passing the liberated hydrogen gas through the reactor and regenerating the oxidising agent.

58. The process of claim 57 , wherein the oxidation of hydrogen gas into water is greater than 95%.

59. The process of claim 57 , wherein the regeneration of the oxidising agent is greater than 90%.

60. The process of claim 57 , wherein the reactor reaches steady state conditions in 3 hours.

Assignments (3)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 039237, FRAME 0147 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065610/0902 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2016
From: MALLINCKRODT LLC
To: MALLINCKRODT NUCLEAR MEDICINE LLC
Reel/Frame 039149/0234 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jul 1, 2016
From: MALLINCKRODT LLC
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 039237/0147 →